IDH2 and astrocytoma (excluding glioblastoma): Demonstrated that G-CIMP’s low methylation profile and CDKN2A/B HD bared an extremely poor prognosis in IDH-mutant astrocytomas, similar to IDH-wildtype glioblastomas.